Identification of potential novel combination antibiotic regimens based on drug-susceptibility and genetic diversity of Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries
Biljana Kakaraskoska Boceska(University of Antwerp), Herman Goossens(University of Antwerp), Seamus O’Brien(Global Antibiotic Research & Development Partnership), Cristina Gardonyi Carvalheiro, Andrew Whitelaw, Tim R. Cressey, Suppawat Boonkasidecha, Kanchana Preedisripipat(ChiangRai Prachanukroh Hospital), Robert Musyimi(Kenya Medical Research Institute), Laura J. V. Piddock(Global Antibiotic Research & Development Partnership), Daynia Ballot(University of the Witwatersrand), Flavia Namiiro(Mulago Hospital), Trusha Nana(University of the Witwatersrand), Christine Lammens(Antwerp University Hospital), Eitan Naaman Berezin(Faculdade de Ciências Médicas da Santa Casa de São Paulo), Charalampos Zarras, Willy Ssengooba(Makerere University), James A. Berkley(Kenya Medical Research Institute), Surbhi Malhotra‐Kumar(University of Antwerp), Emmanuel Roilides(Hippocration General Hospital), Maia De Luca(Bambino Gesù Children's Hospital), Jeannette Wadula(National Health Laboratory Service), Mike Sharland(St George's, University of London), Samir K. Saha(Bangladesh Shishu (Children) Hospital & Institute), Trần Minh Điền(Vietnam National Children's Hospital), Lorenza Romani(Bambino Gesù Children's Hospital), Tuba Vilken(University of Antwerp), Julia Bielicki(St George's, University of London), Angela Dramowski(Unknown), Neal Russell(Médecins Sans Frontières), Mohammad Shahidul Islam(Bangladesh Shishu (Children) Hospital & Institute), Prenika Jaglal(National Health Laboratory Service), Aislinn Cook(St George's, University of London), Hoang Thi Bich Ngoc(Vietnam National Children's Hospital), Sorasak Lochindarat(Queen Sirikit National Institute of Child Health), Sally Ellis(Drugs for Neglected Diseases Initiative), Marisa Márcia Mussi‐Pinhata(Universidade de São Paulo), Y. Glupczynski(University of Antwerp), Renata Maria Augusto da Costa(Global Antibiotic Research & Development Partnership), Cely Barreto da Silva
Cited by 0
Related Papers
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
|The Lancet|2022|16k
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
|The Lancet|2005|3.1k
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
Epidemiology and Clinical Manifestations of Mucormycosis
|Clinical Infectious Diseases|2012|1.5k